Farallon Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,278,900
| Closed | -$277M | – | 389 |
|
|
2021
Q1 | $277M | Buy |
+1,278,900
| New | +$277M | 1.38% | 28 |
|
|
2017
Q2 | – | Sell |
-250,000
| Closed | -$30.2M | – | 88 |
|
|
2017
Q1 | $30.2M | Buy |
250,000
+102,072
| +69% | +$12.3M | 0.33% | 48 |
|
|
2016
Q4 | $16.5M | Buy |
147,928
+116,928
| +377% | +$13.1M | 0.19% | 46 |
|
|
2016
Q3 | $4.12M | Sell |
31,000
-9,000
| -23% | -$1.19M | 0.06% | 58 |
|
|
2016
Q2 | $3.66M | Sell |
40,000
-20,000
| -33% | -$1.83M | 0.05% | 57 |
|
|
2016
Q1 | $4.33M | Buy |
+60,000
| New | +$4.33M | 0.04% | 64 |
|
|
2015
Q3 | – | Sell |
-60,000
| Closed | -$7.37M | – | 101 |
|
|
2015
Q2 | $7.37M | Buy |
+60,000
| New | +$7.37M | 0.1% | 74 |
|
|
2014
Q4 | – | Sell |
-244,000
| Closed | -$19.7M | – | 99 |
|
|
2014
Q3 | $19.7M | Sell |
244,000
-108,500
| -31% | -$8.77M | 0.32% | 55 |
|
|
2014
Q2 | $37.8M | Sell |
352,500
-311,500
| -47% | -$33.4M | 0.55% | 42 |
|
|
2014
Q1 | $39.4M | Buy |
664,000
+80,000
| +14% | +$4.75M | 0.77% | 34 |
|
|
2013
Q4 | $24.3M | Hold |
584,000
| – | – | 0.5% | 46 |
|
|
2013
Q3 | $10.1M | Buy |
584,000
+24,000
| +4% | +$416K | 0.21% | 53 |
|
|
2013
Q2 | $4.93M | Buy |
+560,000
| New | +$4.93M | 0.09% | 65 |
|